Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunologic Memory | 6 | 2021 | 1348 | 1.190 |
Why?
|
CD8-Positive T-Lymphocytes | 12 | 2023 | 4479 | 1.120 |
Why?
|
Hepatitis C, Chronic | 3 | 2021 | 1031 | 0.630 |
Why?
|
Antigens, Viral | 1 | 2021 | 1035 | 0.590 |
Why?
|
Hepacivirus | 2 | 2021 | 1379 | 0.590 |
Why?
|
Epigenesis, Genetic | 7 | 2021 | 3647 | 0.490 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 2 | 2023 | 51 | 0.400 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1341 | 0.360 |
Why?
|
Immunotherapy | 7 | 2023 | 4445 | 0.350 |
Why?
|
Lymphocytic Choriomeningitis | 3 | 2019 | 132 | 0.340 |
Why?
|
Melanoma, Experimental | 3 | 2019 | 561 | 0.300 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2023 | 986 | 0.250 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1038 | 0.240 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 91 | 0.230 |
Why?
|
2-Naphthylamine | 1 | 2021 | 23 | 0.210 |
Why?
|
Lymphocytic choriomeningitis virus | 2 | 2019 | 168 | 0.200 |
Why?
|
Interferons | 3 | 2023 | 706 | 0.200 |
Why?
|
High Mobility Group Proteins | 1 | 2021 | 187 | 0.190 |
Why?
|
Uracil | 1 | 2021 | 165 | 0.180 |
Why?
|
Cyclopropanes | 1 | 2021 | 416 | 0.180 |
Why?
|
Allergy and Immunology | 1 | 2021 | 169 | 0.180 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2019 | 20 | 0.180 |
Why?
|
Valine | 1 | 2021 | 413 | 0.170 |
Why?
|
Lactams, Macrocyclic | 1 | 2021 | 320 | 0.170 |
Why?
|
Ritonavir | 1 | 2021 | 322 | 0.170 |
Why?
|
Proline | 1 | 2021 | 458 | 0.170 |
Why?
|
Ribavirin | 1 | 2021 | 395 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 360 | 0.170 |
Why?
|
Germinal Center | 2 | 2023 | 377 | 0.160 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 253 | 0.160 |
Why?
|
Anilides | 1 | 2021 | 408 | 0.160 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2023 | 5172 | 0.160 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2020 | 520 | 0.150 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 627 | 0.150 |
Why?
|
Chromatin | 2 | 2021 | 2934 | 0.150 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 112 | 0.150 |
Why?
|
Adenosine Deaminase | 1 | 2018 | 241 | 0.140 |
Why?
|
Mice, Inbred C57BL | 9 | 2020 | 21827 | 0.130 |
Why?
|
Immunoglobulin Class Switching | 1 | 2017 | 291 | 0.130 |
Why?
|
B-Lymphocyte Subsets | 1 | 2016 | 246 | 0.130 |
Why?
|
SOXB1 Transcription Factors | 1 | 2016 | 284 | 0.130 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2017 | 659 | 0.120 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2017 | 548 | 0.120 |
Why?
|
T-Box Domain Proteins | 1 | 2016 | 471 | 0.120 |
Why?
|
Autoimmunity | 1 | 2021 | 1349 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2021 | 880 | 0.110 |
Why?
|
Immunoglobulin M | 1 | 2017 | 1537 | 0.110 |
Why?
|
Neoplasms | 4 | 2023 | 21683 | 0.100 |
Why?
|
Antiviral Agents | 2 | 2021 | 2987 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3586 | 0.100 |
Why?
|
Sulfonamides | 1 | 2021 | 1938 | 0.100 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 2007 | 0.100 |
Why?
|
Immunoglobulin E | 1 | 2017 | 1463 | 0.100 |
Why?
|
Anti-Retroviral Agents | 1 | 2021 | 1715 | 0.100 |
Why?
|
Immune Tolerance | 2 | 2019 | 2258 | 0.100 |
Why?
|
Lymph Nodes | 2 | 2019 | 3474 | 0.100 |
Why?
|
Cell Lineage | 2 | 2016 | 2504 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1903 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2133 | 0.080 |
Why?
|
Fibroblasts | 1 | 2019 | 4161 | 0.080 |
Why?
|
Dendritic Cells | 1 | 2019 | 2725 | 0.080 |
Why?
|
Mice | 10 | 2023 | 81183 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4386 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2541 | 0.080 |
Why?
|
Animals | 13 | 2023 | 168757 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 2958 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3309 | 0.070 |
Why?
|
Chronic Disease | 2 | 2021 | 9146 | 0.070 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2019 | 1369 | 0.070 |
Why?
|
Transcription, Genetic | 2 | 2016 | 7722 | 0.070 |
Why?
|
Immunoglobulin G | 1 | 2017 | 4560 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4665 | 0.060 |
Why?
|
HIV-1 | 1 | 2021 | 6939 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4567 | 0.060 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 109 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 2988 | 0.050 |
Why?
|
HIV Infections | 2 | 2021 | 16718 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18029 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 182 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6364 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 244 | 0.050 |
Why?
|
Melanoma | 1 | 2019 | 5510 | 0.050 |
Why?
|
Spheroids, Cellular | 1 | 2023 | 351 | 0.050 |
Why?
|
Cell Differentiation | 3 | 2023 | 11483 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5686 | 0.040 |
Why?
|
Integrin alphaV | 1 | 2019 | 55 | 0.040 |
Why?
|
Caspases | 1 | 2023 | 928 | 0.040 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 5524 | 0.040 |
Why?
|
Mice, Congenic | 1 | 2019 | 99 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2023 | 598 | 0.040 |
Why?
|
Phenotype | 3 | 2021 | 16365 | 0.040 |
Why?
|
RNA, Antisense | 1 | 2018 | 138 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16689 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 2019 | 315 | 0.040 |
Why?
|
Humans | 12 | 2023 | 744343 | 0.040 |
Why?
|
RNA Editing | 1 | 2018 | 148 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2018 | 290 | 0.040 |
Why?
|
Interleukin-21 Receptor alpha Subunit | 1 | 2016 | 18 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9734 | 0.040 |
Why?
|
Organoids | 1 | 2023 | 701 | 0.040 |
Why?
|
Epidermis | 1 | 2019 | 528 | 0.040 |
Why?
|
Interleukin-7 | 1 | 2016 | 142 | 0.030 |
Why?
|
Interferon Type I | 1 | 2019 | 542 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2019 | 635 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2021 | 1423 | 0.030 |
Why?
|
Epitopes | 1 | 2021 | 2571 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2133 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3206 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8428 | 0.030 |
Why?
|
Signal Transduction | 3 | 2021 | 23403 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2019 | 14557 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20822 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2018 | 1366 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 19229 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2540 | 0.030 |
Why?
|
Leadership | 1 | 2021 | 1357 | 0.030 |
Why?
|
Interleukins | 1 | 2016 | 791 | 0.030 |
Why?
|
Antibody Formation | 1 | 2016 | 1402 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3689 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 1222 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2019 | 2132 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3176 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3200 | 0.020 |
Why?
|
Cell Survival | 1 | 2019 | 5882 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1708 | 0.020 |
Why?
|
Cell Movement | 1 | 2019 | 5217 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7322 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4364 | 0.020 |
Why?
|
Female | 6 | 2020 | 380194 | 0.020 |
Why?
|
Transcription Factors | 1 | 2023 | 12208 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10481 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9438 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 12072 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39050 | 0.010 |
Why?
|
Inflammation | 1 | 2018 | 10638 | 0.010 |
Why?
|
Male | 3 | 2021 | 350118 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 63114 | 0.010 |
Why?
|
Adult | 1 | 2021 | 214055 | 0.000 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(83)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_